Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells.

Liu T, Wu LY, Fulton MD, Johnson JM, Berkman CE.

Int J Oncol. 2012 Dec;41(6):2087-92. doi: 10.3892/ijo.2012.1649. Epub 2012 Oct 4.

2.

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.

Ben Jemaa A, Sallami S, Céraline J, Oueslati R.

Cell Biol Int. 2013 May;37(5):464-70. doi: 10.1002/cbin.10055. Epub 2013 Feb 18.

PMID:
23418075
3.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
4.
5.

From AR to c-Met: androgen deprivation leads to a signaling pathway switch in prostate cancer cells.

Liu T, Mendes DE, Berkman CE.

Int J Oncol. 2013 Oct;43(4):1125-30. doi: 10.3892/ijo.2013.2020. Epub 2013 Jul 18.

6.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen.

Evans MJ, Smith-Jones PM, Wongvipat J, Navarro V, Kim S, Bander NH, Larson SM, Sawyers CL.

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9578-82. doi: 10.1073/pnas.1106383108. Epub 2011 May 23.

7.

Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.

Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G.

Prostate. 2013 Sep;73(13):1378-90. doi: 10.1002/pros.22685. Epub 2013 May 31.

PMID:
23728788
8.

In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.

Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS.

Cancer. 1996 May 1;77(9):1862-72.

PMID:
8646686
9.

Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.

Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.

Prostate. 2007 Sep 1;67(12):1293-300.

PMID:
17626246
10.
11.

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. Review.

PMID:
12431817
12.

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.

Eder IE, Hoffmann J, Rogatsch H, Schäfer G, Zopf D, Bartsch G, Klocker H.

Cancer Gene Ther. 2002 Feb;9(2):117-25. Erratum in: Cancer Gene Ther. 2007 Nov;14(11):934.

14.

1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.

Serda RE, Bisoffi M, Thompson TA, Ji M, Omdahl JL, Sillerud LO.

Prostate. 2008 May 15;68(7):773-83. doi: 10.1002/pros.20739.

PMID:
18247401
16.

HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.

Axlund SD, Lambert JR, Nordeen SK.

Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.

17.

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP.

J Urol. 2004 Sep;172(3):1140-4.

PMID:
15311058
18.

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor.

Mizokami A, Koh E, Fujita H, Maeda Y, Egawa M, Koshida K, Honma S, Keller ET, Namiki M.

Cancer Res. 2004 Jan 15;64(2):765-71.

19.

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF.

Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

PMID:
11299720
20.

p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines.

Wong LI, Labrecque MP, Ibuki N, Cox ME, Elliott JE, Beischlag TV.

Chem Biol Interact. 2015 Mar 25;230:40-9. doi: 10.1016/j.cbi.2015.02.002. Epub 2015 Feb 12.

PMID:
25682698

Supplemental Content

Support Center